| John Merlino Iii, | |
|
1 Cowesett Ave, West Warwick, RI 02893-3207 | |
| (401) 826-0879 | |
| (401) 826-2628 |
| Full Name | John Merlino Iii |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1 Cowesett Ave, West Warwick, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336421700 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2777 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Merlino Iii, 1 Cowesett Ave, West Warwick, RI 02893-3207 Ph: () - | John Merlino Iii, 1 Cowesett Ave, West Warwick, RI 02893-3207 Ph: (401) 826-0879 |
News Archive
In recent years, a small but growing number of practices embraced a buffet approach to primary care, offering patients unlimited services for a modest flat fee instead of billing them a la carte for every office visit and test.
Laboratory Corporation of America Holdings, today announced that it has entered into a definitive agreement under which LabCorp will acquire Genzyme Genetics, a business unit of Genzyme Corp., in an all cash transaction valued at $925 million. Net of expected income tax benefits, less acquisition related expenses, the acquisition has a net cash cost to LabCorp of approximately $795 million.
More should be done to celebrate the role of one of Britain's leading institutions, the Medical Research Council, in the development of the gold standard for clinical trial design. Sir Iain Chalmers, writing in the Journal of the Royal Society of Medicine, questions the apparent reluctance of the MRC to take credit for its ground-breaking work in the design and management of randomised multicentre controlled clinical trials in the 1950s.
Sulfa drugs have traditionally been the most frequently prescribed antibiotics for women with uncomplicated UTIs. However, quinolone use has increased with the emergence of sulfa-resistant E. coli strains, which has been shown to approach 20% in some regions of the country.
Abnormal cells in the early embryo are not necessarily a sign that a baby will be born with a birth defect such as Down's syndrome, suggests new research carried out in mice at the University of Cambridge. In a study published today in the journal Nature Communications, scientists show that abnormal cells are eliminated and replaced by healthy cells, repairing - and in many cases completely fixing - the embryo.
› Verified 4 days ago
Dr. Matt Joseph Federico, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1155 Main St, West Warwick, RI 02893 Phone: 401-828-9793 | |
Peter Ishak Hanna Zarif, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1270 Main St, West Warwick, RI 02893 Phone: 401-822-2762 | |
Zahid Hameed, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1734 Main St, West Warwick, RI 02893 Phone: 401-821-7248 | |
Milca Delacruz, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1155 Main St, West Warwick, RI 02893 Phone: 401-828-9797 Fax: 401-828-5813 | |
Diana Laroche, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 834 Providence St, West Warwick, RI 02893 Phone: 401-821-3563 | |
Amanda Mae Fish, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1155 Main St, West Warwick, RI 02893 Phone: 401-828-9793 | |
Stacy Marie Pinault, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 834 Providence St, West Warwick, RI 02893 Phone: 401-821-3563 Fax: 401-823-9238 |